Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
ABS线性增压可控温度区间的研究
ABS系统的制动性能改进设计与分析
ABS系统的控制原理和控制参数
ABS系统结构分析及设计
ABS液压系统仿真与电磁阀优化
ABS有焰燃烧烟密度标准物质的研制
ABS液压控制系统压力变化速率的机理研究
ABS优化模糊控制器设计
ABS与MBS复配对PVC/滑石粉合金性能的影响
ABS与PMMA的共混合金及性能研究
ABS液压系统抗冲击性能研究与仿真分析
ABS衣架式模头的失效分析及其结构改进
ABS硬塑玩具用云纹抗菌色母粒的制备
ABS增韧PC/CF复合材料加工流变行为与力学性能
ABS增韧废PET饮料瓶片的性能与形态研究
ABS阻燃剂的应用与发展趋势
ABS注塑件应力开裂原因及解决措施
ABS在聚合物共混改性中的研究进展
ABS智慧型体验教学理念
ABS制品实用电镀着色工艺
ABS整车道路试验研究
ABS在飞机租赁项目融资中的应用
ABS增韧树脂的本体法制备和力学性能
ABS专用三元共聚涂料树脂的合成
ABS在公租房PFI项目融资中的应用研究
ABS增韧PLA生物降解材料的制备与性能研究
ABT Based Load Frequency Control of Interconnected Power System
ABT and SBT revisited: Efficient memory management techniques for object oriented and web-based applications
ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms
ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein
ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib
ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL
ABT-737 Synergizes with Arsenic Trioxide to Induce Apoptosis of Gastric Carcinoma Cells In Vitro and In Vivo
ABT-737 Induces Bim Expression via JNK Signaling Pathway and Its Effect on the Radiation Sensitivity of HeLa Cells
ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
ABT-737在消化系统肿瘤中的研究现状
ABT-2号生根粉对醉鱼草扦插繁育的影响
ABT-751衍生物的合成及其抗肿瘤活性的研究
ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21((CIP1/WAF1)) in human cancer cells
ABT-199 selectively inhibits BCL2 but not BCL2L1 and efficiently induces apoptosis of chronic lymphocytic leukaemic cells but not platelets
ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease
ABT-450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV
ABT-263 Enhances Sensitivity to Metformin and 2-Deoxyglucose in Pediatric Glioma by Promoting Apoptotic Cell Death
ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection
ABT-724 alleviated hyperactivity and spatial learning impairment in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder
ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy
ABT-6号生根粉处理祁连圆柏扦插育苗技术研究
ABT-1号生根粉对竹柏扦插生根的影响
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice
ABT-450/ritonavir and ABT-267 in combination with ABT-333 for the treatment of hepatitis C virus
ABT-199 partners with azacitidine to contest myeloid malignancies
ABT-869 Inhibits the Proliferation of Ewing Sarcoma Cells and Suppresses Platelet-Derived Growth Factor Receptor beta and c-KIT Signaling Pathways
ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts
ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension
ABT-737, a Bcl-2 Selective Inhibitor, and Chloroquine Synergistically Kill Renal Cancer Cells
ABT-6号生根粉对香水月季扦插生根的影响
ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases
ABT-737 Induces Apoptosis in Mantle Cell Lymphoma Cells with a Bcl-2(high)/Mcl-1(low) Profile and Synergizes with Other Antineoplastic Agents
ABT-737 accelerates butyrate-induced death of HL-60 cells. Involvement of mitochondrial apoptosis pathway
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells
ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation
ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis
ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer
ABT-510 Is an Effective Chemopreventive Agent in the Mouse 4-Nitroquinoline 1-Oxide Model of Oral Carcinogenesis
ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo
ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells
ABT-450: a novel agent for the treatment of CHC genotype 1: focus on treatment-experienced patients
ABT-751 in Relapsed Childhood Acute Lymphoblastic Leukemia
ABT-737 Promotes the Dislocation of ER Luminal Proteins to the Cytosol, Including Pseudomonas Exotoxin
ABT-869, a Multitargeted Receptor Tyrosine Kinase Inhibitor, Reduces Tumor Microvascularity and Improves Vascular Wall Integrity in Preclinical Tumor Models
ABT-737 is highly effective against molecular subgroups of multiple myeloma
ABT-737 Overcomes Resistance to Immunotoxin-Mediated Apoptosis and Enhances the Delivery of Pseudomonas Exotoxin-Based Proteins to the Cell Cytosol
ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress
ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
ABT-737 Synergizes with Bortezomib to Induce Apoptosis, Mediated by Bid Cleavage, Bax Activation, and Mitochondrial Dysfunction in an Akt-Dependent Context in Malignant Human Glioma Cell Lines
ABT-199: Taking Dead Aim at BCL-2
ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer